New pentadienone oxime ester derivatives: synthesis and anti-inflammatory activity. 2018

Qin Li, and Juping Zhang, and Liu Zeng Chen, and Jie Quan Wang, and Hai Ping Zhou, and Wen Jian Tang, and Wei Xue, and Xin Hua Liu
a State Key Laboratory Breeding Base of Green Pesticide and Agricultural Bioengineering , Guizhou University , Guiyang , P. R. China.

To develop novel anti-inflammatory agents, a series of new pentadienone oxime ester compounds were designed and synthesized. The structures were determined by IR, 1H NMR, 13 C NMR, and HRMS. All compounds have been screened for their anti-inflammatory activity by evaluating their inhibition against LPS-induced nitric oxide (NO) release in RAW 264.7 cell. Among them, compound 5j was found to be one of the most potent compounds in inhibiting NO and IL-6 (IC50 values were 6.66 µM and 5.07 µM, respectively). Preliminary mechanism studies show that title compound 5j could significantly suppress expressions of nitric oxide synthase, COX-2, and NO, IL-6 through Toll-like receptor 4/mitogen-activated protein kinases/NF-κB signalling pathway. These data support further studies to assess rational design of more efficient pentadienone oxime ester derivatives with anti-inflammatory activity in the future.

UI MeSH Term Description Entries
D007659 Ketones Organic compounds containing a carbonyl group Ketone
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D009569 Nitric Oxide A free radical gas produced endogenously by a variety of mammalian cells, synthesized from ARGININE by NITRIC OXIDE SYNTHASE. Nitric oxide is one of the ENDOTHELIUM-DEPENDENT RELAXING FACTORS released by the vascular endothelium and mediates VASODILATION. It also inhibits platelet aggregation, induces disaggregation of aggregated platelets, and inhibits platelet adhesion to the vascular endothelium. Nitric oxide activates cytosolic GUANYLATE CYCLASE and thus elevates intracellular levels of CYCLIC GMP. Endogenous Nitrate Vasodilator,Mononitrogen Monoxide,Nitric Oxide, Endothelium-Derived,Nitrogen Monoxide,Endothelium-Derived Nitric Oxide,Monoxide, Mononitrogen,Monoxide, Nitrogen,Nitrate Vasodilator, Endogenous,Nitric Oxide, Endothelium Derived,Oxide, Nitric,Vasodilator, Endogenous Nitrate
D010091 Oximes Compounds that contain the radical R2C Aldoximes,Hydroxyimino Compounds,Ketoxime,Ketoximes,Oxime,Compounds, Hydroxyimino
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004952 Esters Compounds derived from organic or inorganic acids in which at least one hydroxyl group is replaced by an –O-alkyl or another organic group. They can be represented by the structure formula RCOOR’ and are usually formed by the reaction between an acid and an alcohol with elimination of water. Ester
D000067996 RAW 264.7 Cells A transformed macrophage cell line isolated from ASCITES of mice infected with ABELSON MURINE LEUKEMIA VIRUS. RAW 264.7 Cell Line,264.7 Cell, RAW,264.7 Cells, RAW,Cell, RAW 264.7,Cells, RAW 264.7,RAW 264.7 Cell
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000894 Anti-Inflammatory Agents, Non-Steroidal Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. Analgesics, Anti-Inflammatory,Aspirin-Like Agent,Aspirin-Like Agents,NSAID,Non-Steroidal Anti-Inflammatory Agent,Non-Steroidal Anti-Inflammatory Agents,Nonsteroidal Anti-Inflammatory Agent,Anti Inflammatory Agents, Nonsteroidal,Antiinflammatory Agents, Non Steroidal,Antiinflammatory Agents, Nonsteroidal,NSAIDs,Nonsteroidal Anti-Inflammatory Agents,Agent, Aspirin-Like,Agent, Non-Steroidal Anti-Inflammatory,Agent, Nonsteroidal Anti-Inflammatory,Anti-Inflammatory Agent, Non-Steroidal,Anti-Inflammatory Agent, Nonsteroidal,Anti-Inflammatory Analgesics,Aspirin Like Agent,Aspirin Like Agents,Non Steroidal Anti Inflammatory Agent,Non Steroidal Anti Inflammatory Agents,Nonsteroidal Anti Inflammatory Agent,Nonsteroidal Anti Inflammatory Agents,Nonsteroidal Antiinflammatory Agents
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

Qin Li, and Juping Zhang, and Liu Zeng Chen, and Jie Quan Wang, and Hai Ping Zhou, and Wen Jian Tang, and Wei Xue, and Xin Hua Liu
May 2024, Chemistry & biodiversity,
Qin Li, and Juping Zhang, and Liu Zeng Chen, and Jie Quan Wang, and Hai Ping Zhou, and Wen Jian Tang, and Wei Xue, and Xin Hua Liu
July 2015, Bioorganic & medicinal chemistry letters,
Qin Li, and Juping Zhang, and Liu Zeng Chen, and Jie Quan Wang, and Hai Ping Zhou, and Wen Jian Tang, and Wei Xue, and Xin Hua Liu
April 2010, European journal of medicinal chemistry,
Qin Li, and Juping Zhang, and Liu Zeng Chen, and Jie Quan Wang, and Hai Ping Zhou, and Wen Jian Tang, and Wei Xue, and Xin Hua Liu
August 2010, Bioorganic & medicinal chemistry letters,
Qin Li, and Juping Zhang, and Liu Zeng Chen, and Jie Quan Wang, and Hai Ping Zhou, and Wen Jian Tang, and Wei Xue, and Xin Hua Liu
March 2016, Bioorganic & medicinal chemistry letters,
Qin Li, and Juping Zhang, and Liu Zeng Chen, and Jie Quan Wang, and Hai Ping Zhou, and Wen Jian Tang, and Wei Xue, and Xin Hua Liu
October 1999, Arzneimittel-Forschung,
Qin Li, and Juping Zhang, and Liu Zeng Chen, and Jie Quan Wang, and Hai Ping Zhou, and Wen Jian Tang, and Wei Xue, and Xin Hua Liu
July 2021, International journal of molecular sciences,
Qin Li, and Juping Zhang, and Liu Zeng Chen, and Jie Quan Wang, and Hai Ping Zhou, and Wen Jian Tang, and Wei Xue, and Xin Hua Liu
May 1998, Bioorganic & medicinal chemistry letters,
Qin Li, and Juping Zhang, and Liu Zeng Chen, and Jie Quan Wang, and Hai Ping Zhou, and Wen Jian Tang, and Wei Xue, and Xin Hua Liu
January 2018, RSC advances,
Qin Li, and Juping Zhang, and Liu Zeng Chen, and Jie Quan Wang, and Hai Ping Zhou, and Wen Jian Tang, and Wei Xue, and Xin Hua Liu
February 1965, Journal of pharmaceutical sciences,
Copied contents to your clipboard!